Antimicrobial resistance (AMR) jeopardizes the progress made in combating infectious disease, putting efforts to modernize health care at risk.
AMR is a unique public health challenge as it involves dozens of different pathogens that are constantly evolving and transferring new mechanisms of resistance. AMR is a One Health issue, recognizing that the health of people is connected to the health of animals and the environment. Governments, businesses and philanthropies can work together to address the health threat of AMR.
The CDC Foundation has established an AMR Fund to assist CDC and its partners to continue making meaningful progress across the spectrum of AMR: from improving antibiotic use, including access to lifesaving drugs, to investing in innovative ways to prevent and treat these infections.
The AMR Fund will mobilize financial support and progress in the five areas associated with the U.S Department of Health and Human Services and CDC's AMR Challenge:
- Tracking and data—Sharing data and improving data collection to stay ahead of antibiotic resistance and prevent infections.
- Infection prevention and control—Preventing infections and reducing the spread of germs.
- Antibiotic use–Improving the use of antibiotics, including ensuring access.
- Environment and sanitation—Keeping antibiotics and antibiotic-resistant threats from entering the environment.
- Vaccines, therapeutics and diagnostics—Developing and improving access to vaccines, therapeutics and diagnostics for better prevention, treatment and detection.
